• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

身体组成影响胰腺手术患者的术后并发症以及90天生存率和总生存率。

Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients.

作者信息

Velho Sónia, Costa Santos Maria Pia, Cunha Cátia, Agostinho Lisa, Cruz Rita, Costa Filipe, Garcia Mafalda, Oliveira Paulo, Maio Rui, Baracos Vickie E, Cravo Marília

机构信息

Dietetics and Nutrition, Hospital Beatriz Ângelo, Loures, Portugal.

Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal.

出版信息

GE Port J Gastroenterol. 2020 Dec;28(1):13-25. doi: 10.1159/000507206. Epub 2020 May 19.

DOI:10.1159/000507206
PMID:33564701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7841797/
Abstract

INTRODUCTION

Pancreatic surgery still carries a high morbidity and mortality even in specialized centers. The aim of this study was to evaluate the influence of patients' body composition on postoperative complications and survival after pancreatic surgery.

METHODS

This was a retrospective study on patients undergoing pancreatic surgery between March 2012 and December 2017. Demographics, clinical data, and postoperative complications classified according to Clavien-Dindo were recorded. Body composition was assessed using routine diagnostic or staging computed tomography (CT). Multiple Cox proportional hazards models were adjusted.

RESULTS

Ninety patients were included, 55% were male, and the mean age was 68 ± 10.9 years. Of these 90, 92% had a total pancreatectomy or pancreaticoduodenectomy, 7% a distal pancreatectomy, and 1% a pancreaticoduodenectomy with multi-visceral resection; 84% had malignant disease. The incidence of major complications was 27.8% and the 90-day mortality was 8.8%. The ratio of visceral fat area/skeletal muscle area (VFA:SMA) was associated with an increased risk of complications (OR 2.24, 95% CI 1.14-4.87, = 0.03) and 90-day survival (HR 2.13, 95% CI 1.13-4.01, = 0.019). On simple analysis, shorter overall survival (OS) was observed in patients aged ≥70 years ( = 0.0009), with postoperative complications ≥IIIb ( = 0.01), an increased VFA:SMA ( = 0.007), and decreased muscle radiation attenuation ( = 1.6 × 10). In an OS model adjusted for age, disease malignancy, postoperative complications, and body composition parameters, muscle radiation attenuation remained significantly associated with survival (HR 0.94, 95% CI 0.90-0.98, = 0.0016). A model which included only body composition variables had a discrimination ability (-statistic 0.76) superior to a model which comprised conventional clinical variables (-statistic 0.68).

CONCLUSION

Body composition is a major determinant of postoperative complications and survival in pancreatic surgery patients.

摘要

引言

即使在专业中心,胰腺手术的发病率和死亡率仍然很高。本研究的目的是评估患者身体组成对胰腺手术后并发症和生存的影响。

方法

这是一项对2012年3月至2017年12月期间接受胰腺手术患者的回顾性研究。记录了人口统计学、临床数据以及根据Clavien-Dindo分类的术后并发症。使用常规诊断或分期计算机断层扫描(CT)评估身体组成。调整了多个Cox比例风险模型。

结果

纳入90例患者,55%为男性,平均年龄为68±10.9岁。在这90例患者中,92%进行了全胰切除术或胰十二指肠切除术,7%进行了胰体尾切除术,1%进行了多脏器切除的胰十二指肠切除术;84%患有恶性疾病。主要并发症的发生率为27.8%,90天死亡率为8.8%。内脏脂肪面积/骨骼肌面积(VFA:SMA)比值与并发症风险增加(OR 2.24,95%CI 1.14 - 4.87,P = 0.03)和90天生存率(HR 2.13,95%CI 1.13 - 4.01,P = 0.019)相关。简单分析显示,年龄≥70岁的患者总体生存期(OS)较短(P = 0.0009),术后并发症≥IIIb级的患者(P = 0.01),VFA:SMA增加(P = 0.007)以及肌肉辐射衰减降低(P = 1.6×10)。在根据年龄、疾病恶性程度、术后并发症和身体组成参数调整的OS模型中,肌肉辐射衰减仍与生存显著相关(HR 0.94,95%CI 0.90 - 0.98,P = 0.0016)。仅包含身体组成变量的模型的判别能力(C统计量0.76)优于包含传统临床变量的模型(C统计量0.68)。

结论

身体组成是胰腺手术患者术后并发症和生存的主要决定因素。

相似文献

1
Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients.身体组成影响胰腺手术患者的术后并发症以及90天生存率和总生存率。
GE Port J Gastroenterol. 2020 Dec;28(1):13-25. doi: 10.1159/000507206. Epub 2020 May 19.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.低骨骼肌辐射衰减和内脏肥胖与胰腺癌患者的总生存期及手术部位感染相关。
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):317-326. doi: 10.1002/jcsm.12155. Epub 2016 Oct 26.
4
Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.肌肉减少症和内脏肥胖对胰腺癌手术后死亡率和胰瘘的影响。
Br J Surg. 2016 Mar;103(4):434-42. doi: 10.1002/bjs.10063. Epub 2016 Jan 18.
5
Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.术前肌少症与胰十二指肠切除术后胰腺癌患者的总体生存不良相关。
Eur Radiol. 2021 Apr;31(4):2472-2481. doi: 10.1007/s00330-020-07294-7. Epub 2020 Sep 24.
6
A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer.高内脏脂肪组织与骨骼肌比值作为癌症胰十二指肠切除术后主要并发症的决定因素。
Nutrition. 2016 Nov-Dec;32(11-12):1231-7. doi: 10.1016/j.nut.2016.04.002. Epub 2016 Apr 22.
7
Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer.骨骼肌质量与壶腹周围非胰腺癌胰十二指肠切除术后较差的生存率相关。
Ann Surg Oncol. 2017 Jan;24(1):272-280. doi: 10.1245/s10434-016-5495-6. Epub 2016 Sep 8.
8
Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study.体质组成、肌肉力量和身体机能对胃癌根治术后并发症和生存的影响:一项大规模前瞻性研究的综合分析。
Clin Nutr. 2021 May;40(5):3360-3369. doi: 10.1016/j.clnu.2020.11.007. Epub 2020 Nov 11.
9
Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.基于临床获取的 CT 和 MRI 分析,肌肉减少症和内脏肥胖对胰十二指肠切除术后胰瘘的预测价值。
Eur Radiol. 2019 May;29(5):2417-2425. doi: 10.1007/s00330-018-5790-7. Epub 2018 Nov 7.
10
Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.内脏脂肪堆积和肌少型内脏肥胖与胰腺癌切除术后预后不良相关。
Ann Surg Oncol. 2017 Nov;24(12):3732-3740. doi: 10.1245/s10434-017-6077-y. Epub 2017 Sep 5.

引用本文的文献

1
Impact of Preoperative Malnutrition on Patients with Pancreatic Neoplasms Post-Duodenopancreatectomy: A Retrospective Cohort Study.术前营养不良对胰十二指肠切除术后胰腺肿瘤患者的影响:一项回顾性队列研究。
Nutrients. 2024 Jun 12;16(12):1839. doi: 10.3390/nu16121839.
2
Phase Angle and Postoperative Complications in a Model of Immunonutrition in Patients with Pancreatic Cancer.相位角与免疫营养支持治疗胰腺癌患者术后并发症的相关性研究
Nutrients. 2023 Oct 11;15(20):4328. doi: 10.3390/nu15204328.
3
Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors.癌症幸存者全身脂肪量和骨骼肌指数与全因死亡率及癌症特异性死亡率的关联。
Cancers (Basel). 2023 Feb 8;15(4):1081. doi: 10.3390/cancers15041081.
4
Selected Body Composition Parameters Analysis Based on Bioelectrical Impedance in Patients Operated for Gastrointestinal Cancer.基于生物电阻抗的胃肠道癌术后患者身体成分参数分析。
In Vivo. 2022 Nov-Dec;36(6):2936-2944. doi: 10.21873/invivo.13036.
5
High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma.高全身免疫炎症指数与可切除胰腺导管腺癌的低骨骼肌量相关。
Front Oncol. 2022 Feb 28;12:827755. doi: 10.3389/fonc.2022.827755. eCollection 2022.

本文引用的文献

1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.FOLFIRINOX 或吉西他滨作为胰腺癌的辅助治疗。
N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
2
Impact of sarcopenia on outcomes of patients undergoing pancreatectomy: A retrospective analysis of 107 patients.肌肉减少症对接受胰腺切除术患者预后的影响:107例患者的回顾性分析
Medicine (Baltimore). 2018 Sep;97(39):e12076. doi: 10.1097/MD.0000000000012076.
3
Borderline resectable pancreatic cancer. Challenges and controversies.交界可切除胰腺癌。挑战与争议。
Cancer Treat Rev. 2018 Jul;68:124-135. doi: 10.1016/j.ctrv.2018.06.006. Epub 2018 Jun 13.
4
Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.骨骼肌减少症和肌内脂肪增多症在胰腺和壶腹周围腺癌患者中伴随着不同的生物学特征。
PLoS One. 2018 May 3;13(5):e0196235. doi: 10.1371/journal.pone.0196235. eCollection 2018.
5
Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.肌肉减少症对接受立体定向体部放射治疗的可切除边缘和局部晚期胰腺癌患者的影响。
J Gastrointest Oncol. 2018 Feb;9(1):24-34. doi: 10.21037/jgo.2017.09.13.
6
Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.胃癌手术中的肌肉减少症和合并症作为一个有用的综合因素预测其他原因导致的最终死亡。
Ann Surg Oncol. 2018 May;25(5):1160-1166. doi: 10.1245/s10434-018-6354-4. Epub 2018 Feb 5.
7
Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer.术前肌肉减少症和术后肌肉加速丢失会对胰腺癌切除术后的生存产生负面影响。
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):326-334. doi: 10.1002/jcsm.12274. Epub 2018 Feb 5.
8
Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?计算机断层扫描诊断 725 例肿瘤患者恶病质和肌肉减少症:营养筛查是否能发现隐匿性营养不良?
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):295-305. doi: 10.1002/jcsm.12258. Epub 2017 Dec 21.
9
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.2017 年国际胰腺导管腺癌边界可切除定义和标准的共识。
Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22.
10
Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.超越肌肉减少症:可治愈乳腺癌人群骨骼肌数量和放射密度的特征及整合
Breast J. 2018 May;24(3):278-284. doi: 10.1111/tbj.12952. Epub 2017 Nov 15.